Peer Review reports
From: ARL9 is upregulated and serves as a biomarker for a poor prognosis in colon adenocarcinoma
| Original Submission | ||
|---|---|---|
| 28 Nov 2022 | Submitted | Original manuscript |
| 7 Dec 2022 | Reviewed | Reviewer Report - Mansoor-ali Vaali-mohammed |
| 12 Dec 2022 | Reviewed | Reviewer Report |
| 1 Jan 2023 | Author responded | Author comments - Ling-ling Yan |
| Resubmission - Version 2 | ||
| 1 Jan 2023 | Submitted | Manuscript version 2 |
| 14 Jan 2023 | Author responded | Author comments - Ling-ling Yan |
| Resubmission - Version 3 | ||
| 14 Jan 2023 | Submitted | Manuscript version 3 |
| 20 Jan 2023 | Author responded | Author comments - Ling-ling Yan |
| Resubmission - Version 4 | ||
| 20 Jan 2023 | Submitted | Manuscript version 4 |
| 12 Feb 2023 | Reviewed | Reviewer Report - Mansoor-ali Vaali-mohammed |
| Resubmission - Version 5 | ||
| Submitted | Manuscript version 5 | |
| Publishing | ||
| 13 Feb 2023 | Editorially accepted | |
| 23 Feb 2023 | Article published | 10.1186/s12876-023-02677-8 |
You can find further information about peer review here.